drugset / Trial / NCT04882878
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of nipocalimab versus placebo in participants with active systemic lupus erythematosus (SLE).
Timeline
- Start
- 2021-08-20
- Primary completion
- 2024-04-30
- Completion
- 2024-12-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nipocalimab | Monoclonal antibody | — | Intravenous |